Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CRDF	CARDIFF ONCOLOGY INC	$122.38M	-95.50%	-71.50%	-128.96%	-123.40%	0.42	3.27	100.00%	-8,530.90%	-8,526.10%
ANVS	ANNOVIS BIO INC	$74.49M	-318.10%	-215.50%	-1,185.14%	1,243.50%	4.20	1.27	N/A	N/A	N/A
CRVO	CERVOMED INC	$28.61M	-136.10%	-112.60%	-282.94%	-221.00%	0.42	3.36	100.00%	-1,437.80%	-1,437.83%
HELP	CYBIN INC	$229.51M	-65.60%	-55.90%	-48.03%	-428.20%	0.06	13.78	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$42.80M	-84.90%	-72.40%	-123.47%	2,579.00%	0.25	4.92	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$12.75M	N/A	-147.30%	-196.95%	671.60%	0.54	1.38	N/A	N/A	N/A
VKTX	VIKING THERAPEUTICS INC	$3.56B	-71.30%	-65.30%	-94.11%	-84.60%	0.21	5.72	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$1.36B	-86.40%	-61.10%	-70.26%	-174.80%	0.58	8.60	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$14.43M	-51.30%	-44.10%	-54.42%	-76.20%	0.17	5.17	100.00%	-1,227.10%	-1,220.63%
GLMD	GALMED PHARMACEUTICALS LTD	$3.82M	-57.00%	-50.40%	-70.02%	-80.70%	0.18	6.55	N/A	N/A	N/A
ADXN	ADDEX THERAPEUTICS LTD	$8.27M	-102.60%	-84.90%	-129.96%	-146.70%	0.34	1.40	100.00%	-3,892.30%	-3,883.32%
HSCS	HEARTSCIENCES INC	$6.18M	-333.40%	-140.20%	-236.78%	-632.60%	1.85	1.19	57.90%	-97,881.00%	-89,741.82%
IMMP	IMMUTEP LTD	$70.74M	-61.80%	-50.90%	-83.72%	-144.80%	0.49	2.97	100.00%	-777.70%	-777.30%
ADIL	ADIAL PHARMACEUTICALS INC	$4.93M	-162.80%	-127.60%	-209.05%	1,628.60%	0.41	3.18	N/A	N/A	N/A
ADGM	ADAGIO MEDICAL HOLDINGS INC	$18.77M	-382.50%	-65.00%	-69.45%	-110.10%	5.87	1.85	N/A	N/A	N/A
MGRX	MANGOCEUTICALS INC	$7.52M	-126.20%	-118.30%	-139.22%	4,034.50%	0.07	0.29	52.40%	-4,845.60%	-4,604.56%
ABVC	ABVC BIOPHARMA INC	$28.86M	-84.30%	-44.10%	-58.30%	-56.30%	0.64	0.12	N/A	N/A	N/A
PIII	P3 HEALTH PARTNERS INC	$100.42M	N/A	-18.40%	-49.25%	88.80%	-5.57	0.33	-2.20%	-8.60%	-4.97%
ITOC	ITONIC HOLDINGS LTD	$5.13M	-82.80%	-64.50%	-59.05%	-319.70%	0.16	8.83	62.60%	-974.70%	-974.68%
SILO	SILO PHARMA INC	$6.12M	-88.40%	-70.00%	-76.11%	-283.90%	0.24	9.65	11.90%	-6,717.40%	-6,663.85%
SRXH	SRX HEALTH SOLUTIONS INC	$76.14M	N/A	-160.90%	-246.01%	-518.30%	1.37	1.72	17.90%	269.30%	266.89%
TBRG	TRUBRIDGE INC	$388.48M	2.50%	1.10%	3.21%	5.40%	1.28	1.78	53.20%	1.30%	3.21%
TELO	TELOMIR PHARMACEUTICALS INC	$89.41M	-201.20%	-172.70%	-185.87%	1,542.50%	0.17	7.00	N/A	N/A	N/A
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$1.93B	-187.60%	-37.80%	-51.15%	-67.80%	1.99	1.79	91.50%	-216.50%	-205.84%
XBIT	XBIOTECH INC	$75.61M	-26.10%	-25.10%	-29.16%	-196.20%	0.04	39.03	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$1.22M	N/A	N/A	N/A	N/A	0.08	8.09	N/A	N/A	N/A
OGEN	ORAGENICS INC	$2.66M	-177.30%	-121.30%	-151.99%	-1,916.60%	0.21	5.73	N/A	N/A	N/A
SNTI	SENTI BIOSCIENCES HOLDINGS INC	$30.65M	-503.80%	-97.90%	-215.02%	-104.90%	13.91	1.04	100.00%	-135,650.00%	-135,650.00%
NXL	NEXALIN TECHNOLOGY INC	$8.21M	-191.90%	-166.40%	-288.63%	-252.80%	0.28	4.07	82.00%	-3,022.90%	-3,022.94%
NXGL	NEXGEL INC	$4.89M	-70.20%	-29.60%	-38.15%	-40.00%	1.78	1.70	38.90%	-28.50%	-28.05%
NVNO	ENVVENO MEDICAL CORP	$7.28M	-66.40%	-60.40%	-78.56%	-69.30%	0.10	11.89	N/A	N/A	N/A
PPCB	PROPANC BIOPHARMA INC	$3.94M	-159.00%	-115.10%	-163.04%	-134.00%	0.36	2.37	N/A	N/A	N/A
NTRB	NUTRIBAND INC	$42.42M	-431.90%	-372.10%	-121.34%	-1,952.40%	0.13	6.36	27.80%	-1,475.20%	-402.97%
PLSM	PULSENMORE LTD	$26.01M	-17.60%	-13.00%	-21.35%	-22.20%	0.23	7.88	84.20%	-39.60%	-48.82%
PLUR	PLURI INC	$24.82M	N/A	-79.20%	410.69%	-103.50%	-1.85	0.33	43.00%	-2,366.90%	-2,264.32%
NSYS	NORTECH SYSTEMS INC	$34.18M	3.00%	1.40%	6.04%	4.20%	1.21	1.84	16.10%	0.80%	2.16%
NSRX	NASUS PHARMA LTD	$25.87M	N/A	-204.70%	-208.87%	22,392.50%	0.81	2.25	N/A	N/A	N/A
PMI	PICARD MEDICAL INC	$10.63M	N/A	-180.80%	-559.93%	493.70%	4.95	1.11	-4.10%	-546.60%	-436.72%
NRSN	NEUROSENSE THERAPEUTICS LTD	$25.17M	-2,175.00%	-397.10%	747.65%	936.10%	-1.66	0.31	N/A	N/A	N/A
MODD	MODULAR MEDICAL INC	$10.75M	-245.80%	-190.80%	-331.40%	-525.60%	0.74	1.59	N/A	N/A	N/A
PRFX	PRF TECHNOLOGIES LTD	$1.20M	-96.90%	-60.80%	-53.59%	309.90%	0.32	1.78	-311.80%	-29,541.20%	-30,129.41%
NOTV	INOTIV INC	$9.56M	-74.70%	-11.70%	-30.17%	-11.70%	8.11	0.27	22.90%	-17.10%	-9.64%
SNYR	SYNERGY CHC CORP	$3.71M	N/A	-110.70%	2,278.03%	-26.90%	-1.25	0.93	65.40%	-57.00%	-31.84%
AIXC	AIXCRYPTO HOLDINGS INC	$27.92M	-105.90%	-89.50%	-89.08%	-274.90%	0.09	11.57	N/A	N/A	N/A
NMTC	NEUROONE MEDICAL TECHNOLOGIES CORP	$33.62M	-98.30%	-69.80%	-107.58%	-247.30%	0.46	4.38	54.50%	-68.30%	-68.34%
REVB	REVELATION BIOSCIENCES INC	$4.22M	-234.50%	-191.70%	-72.44%	1,253.20%	0.16	10.02	N/A	N/A	N/A
PULM	PULMATRIX INC	$5.00M	-102.10%	-91.60%	-126.04%	1,823.20%	0.25	4.96	N/A	N/A	N/A
NYXH	NYXOAH SA	$123.49M	-159.80%	-78.50%	-129.21%	-210.60%	1.72	0.99	60.70%	-545.70%	-476.63%
CDT	CDT EQUITY INC	$5.93M	-4,720.10%	-531.60%	542.61%	-64,841.70%	-1.79	0.34	N/A	N/A	N/A
NIVF	NEWGENIVF GROUP LTD	$2.55M	77.20%	54.40%	34.58%	127.40%	0.25	3.12	20.20%	209.00%	222.07%
NEUP	NEUPHORIA THERAPEUTICS INC	$27.67M	-76.90%	-54.80%	-53.47%	815.70%	0.18	14.31	100.00%	131,387.10%	134,189.48%
NEPH	NEPHROS INC	$40.06M	7.70%	5.90%	7.00%	13.60%	0.29	4.55	59.90%	4.10%	4.13%
NCEL	NEWCELX LTD	$15.26M	-191.80%	-121.40%	-114.48%	549.10%	0.58	0.76	N/A	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-2.00%	-4.75%	3.60%	4.94	0.34	100.00%	-150.00%	-101.75%
NAKA	NAKAMOTO INC	$115.55M	-84.80%	-56.50%	-75.51%	-65.40%	0.69	0.25	94.30%	-7,397.80%	-7,110.12%
MTVA	METAVIA INC	$14.82M	-172.90%	-89.40%	-142.73%	213.00%	0.59	2.73	N/A	N/A	N/A
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$4.29M	-204.30%	-131.30%	-283.08%	-259.00%	0.94	1.32	N/A	N/A	N/A
RVP	RETRACTABLE TECHNOLOGIES INC	$20.24M	-8.80%	-4.50%	-4.87%	-4.70%	0.96	5.74	-2.10%	-17.60%	-16.68%
MRKR	MARKER THERAPEUTICS INC	$23.84M	-73.30%	-59.70%	-79.09%	1,100.20%	0.26	4.79	100.00%	-340.80%	-341.26%
MREO	MEREO BIOPHARMA GROUP PLC	$43.42M	-81.30%	-70.40%	-108.53%	3,614.50%	0.19	6.48	73.60%	-7,142.00%	-7,474.80%
MOLN	MOLECULAR PARTNERS AG	$142.54M	-66.10%	-54.50%	-68.60%	-267.80%	0.28	9.43	N/A	N/A	N/A
MNOV	MEDICINOVA INC	$67.43M	-27.30%	-25.20%	-29.57%	-459.50%	0.08	9.09	8.00%	-1,964.30%	-1,963.34%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$0.00	-91.90%	-66.30%	-75.11%	-68.20%	0.44	1.30	-202.30%	-633.60%	-575.29%
IMNN	IMUNON INC	$9.03M	-341.20%	-153.80%	-380.06%	-13,342.30%	1.39	1.59	N/A	N/A	N/A
SEER	SEER INC	$97.32M	-26.60%	-23.50%	-26.87%	-26.50%	0.13	17.73	48.70%	-464.80%	-464.06%
SERA	SERA PROGNOSTICS INC	$70.49M	-41.00%	-30.90%	-45.82%	-41.90%	0.38	2.12	-191.20%	-56,386.00%	-56,373.68%
NUWE	NUWELLIS INC	$2.67M	-32,691.80%	-251.70%	-262.80%	-508.70%	1.61	1.56	65.50%	-217.20%	-96.83%
PFSA	PROFUSA INC	$1.72M	N/A	-1,097.10%	124.52%	476.20%	-1.03	0.02	N/A	N/A	N/A
MNDR	MOBILE-HEALTH NETWORK SOLUTIONS	$3.21M	-47.60%	-36.50%	-30.96%	-353.70%	0.19	4.22	19.70%	-35.30%	-35.33%
MLSS	MILESTONE SCIENTIFIC INC	$34.35M	-166.30%	-56.60%	-145.72%	-135.20%	2.49	1.51	71.00%	-51.30%	-50.83%
MIRA	MIRA PHARMACEUTICALS INC	$41.52M	-450.30%	-431.80%	-104.92%	-294.40%	0.01	82.16	N/A	N/A	N/A
SLXN	SILEXION THERAPEUTICS CORP	$1.99M	-655.80%	-224.20%	-2,989.11%	-1,079.30%	14.81	1.00	N/A	N/A	N/A
CTOR	CITIUS ONCOLOGY INC	$77.08M	-99.50%	-42.20%	-99.44%	-83.90%	1.86	0.50	80.10%	-757.60%	-742.27%
MDCX	MEDICUS PHARMA LTD	$16.20M	-5,695.90%	-520.00%	-2,641.77%	1,716.90%	4.52	1.22	N/A	N/A	N/A
OKYO	OKYO PHARMA LTD	$64.60M	N/A	-123.50%	183.14%	79.90%	-2.36	0.58	N/A	N/A	N/A
MBIO	MUSTANG BIO INC	$4.63M	-35.40%	-16.40%	-31.13%	32.20%	0.93	2.12	N/A	N/A	N/A
MBAI	CHECK-CAP LTD	$13.06M	416.70%	105.30%	120.80%	878.70%	1.18	0.05	N/A	N/A	N/A
MASI	MASIMO CORP	$9.35B	9.10%	4.00%	10.26%	8.10%	1.08	2.68	61.70%	4.90%	8.67%
GRML	GREENLAND MINES LTD	$47.04M	-108.80%	-98.30%	-34.49%	-6,638.20%	0.16	19.74	N/A	N/A	N/A
LUCY	INNOVATIVE EYEWEAR INC	$6.35M	-83.40%	-76.00%	-96.81%	-270.40%	0.13	8.02	17.50%	-272.50%	-272.48%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$3.59M	-408.30%	-138.10%	-306.82%	303.00%	2.53	0.30	N/A	N/A	N/A
LNAI	LUNAI BIOWORKS INC	$10.52M	N/A	-1,617.80%	1,355.58%	749.20%	-2.03	0.19	100.00%	-612,568.10%	-609,894.27%
SXTC	CHINA SXT PHARMACEUTICALS INC	$1.27M	-50.30%	-30.90%	-41.06%	4,390.00%	0.30	4.37	654,226.10%	-4,820,590.80%	-4,550,441.85%
SXTP	60 DEGREES PHARMACEUTICALS INC	$3.96M	-212.90%	-140.20%	-154.89%	-702.10%	0.42	3.34	-22.60%	-2,028.70%	-1,904.80%
TALK	TALKSPACE INC	$869.39M	1.00%	0.90%	-2.55%	-4.10%	0.21	4.84	42.20%	0.50%	-1.21%
TTRX	TURN THERAPEUTICS INC	$148.05M	-117.30%	-38.90%	-28.39%	-304.20%	2.05	2.23	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$11.04M	N/A	-671.50%	10,974.32%	234.70%	-22.04	0.96	N/A	N/A	N/A
AEON	AEON BIOPHARMA INC	$21.60M	N/A	-695.20%	-3,065.27%	-461.40%	-1.52	0.99	N/A	N/A	N/A
SER	SERINA THERAPEUTICS INC	$28.30M	-407.70%	-155.10%	-99.43%	-13,025.00%	0.55	4.18	100.00%	-16,583.10%	-16,030.77%
LFWD	LIFEWARD LTD	$17.84M	-243.10%	-97.40%	-110.42%	-267.70%	4.31	2.40	36.60%	-123.70%	-120.25%
KYNB	KYNTRA BIO INC	$28.09M	-208.50%	120.20%	211.56%	172.20%	-2.72	3.61	40.70%	2,199.40%	2,318.26%
SKYE	SKYE BIOSCIENCE INC	$25.13M	-217.30%	-162.40%	-636.11%	-450.60%	1.16	1.78	N/A	N/A	N/A
KAPA	KAIROS PHARMA LTD	$11.84M	-92.30%	-86.40%	-109.90%	-284.40%	0.08	10.31	N/A	N/A	N/A
TCRT	ALAUNOS THERAPEUTICS INC	$5.64M	-165.90%	-123.50%	-319.02%	-490.80%	0.46	1.63	100.00%	-136,966.70%	-136,966.67%
KALV	KALVISTA PHARMACEUTICALS INC	$1.43B	N/A	N/A	N/A	N/A	-17.74	5.17	N/A	N/A	N/A
IVF	INVO FERTILITY INC	$597.65k	-475.60%	-100.40%	-293.09%	-7,843.00%	2.22	0.12	39.20%	-420.60%	-404.68%
DCOY	DECOY THERAPEUTICS INC	$3.42M	-395.40%	-193.30%	-336.14%	476.10%	1.17	1.84	N/A	N/A	N/A
QUCY	QUANTUM CYBER NV	$52.19M	N/A	N/A	N/A	N/A	0.68	2.11	N/A	N/A	N/A
QNRX	QUOIN PHARMACEUTICALS LTD	$17.05M	-292.60%	-132.20%	-164.21%	-369.40%	0.79	2.87	N/A	N/A	N/A
POCI	PRECISION OPTICS CORPORATION INC	$54.07M	-37.50%	-20.00%	-20.25%	-65.20%	0.68	2.10	13.80%	-17.00%	-16.44%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	602	+0.98%	-2.57%	-1.90%	-76.05%	18.28x	4.87x	-122.61%	-12.79%	-9.65%	+63.30%	Strong Buy
Diagnostics & Research	55	+0.67%	+2.81%	-8.17%	+10.83%	15.48x	3.33x	-6.63%	+6.21%	+12.47%	+27.83%	Strong Buy
Drug Manufacturers - General	20	+1.56%	+1.86%	+5.32%	+34.81%	35.69x	7.08x	+34.51%	+12.30%	+21.70%	+16.21%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.45%	+0.08%	-0.21%	-29.54%	10.90x	1.56x	+9.35%	+5.09%	+10.99%	+40.37%	Buy
Healthcare Plans	10	-0.67%	-2.56%	+17.39%	-0.56%	26.31x	2.31x	+9.02%	+2.82%	+6.93%	+0.78%	Buy
Health Information Services	53	-0.32%	+2.09%	+1.61%	-27.61%	18.03x	2.95x	-3.94%	+0.71%	+1.12%	+39.60%	Buy
Medical Care Facilities	50	-0.91%	-2.48%	+4.38%	-21.64%	15.15x	4.82x	-49.93%	+6.78%	+15.36%	+22.72%	Buy
Medical Devices	139	+0.14%	+3.57%	-2.51%	-69.30%	23.09x	3.04x	+6.44%	+5.41%	+9.00%	+33.12%	Strong Buy
Medical Distribution	10	+1.07%	+2.30%	-9.07%	+5.35%	22.37x	143.42x	-104.83%	+3.78%	+25.68%	+28.40%	Buy
Medical Instruments & Supplies	55	+0.20%	+3.38%	-1.50%	-5.73%	42.68x	3.27x	+7.01%	+7.29%	+10.77%	+27.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 42.55% over the past year, overperforming other healthcare stocks by 102 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 57.98% from Bioventus's current stock price of $9.50.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 7 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 122.45% over the past year, overperforming other healthcare stocks by 181 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $251.09, an upside of 4.88% from Jazz Pharmaceuticals's current stock price of $239.40.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 72.73% have issued a Strong Buy rating, 27.27% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 234.79% over the past year, overperforming other healthcare stocks by 294 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 28.14% from Indivior Pharmaceuticals's current stock price of $37.46.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 75 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

Cryo Cell International's dividend payout ratio of -45.5% indicates that its dividend yield might not be sustainable for the long-term.

2. So Young International (NASDAQ:SY)

So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 30.19%, which is 28 percentage points higher than the healthcare sector average of 2.66%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.58% in the last day, and up 0.01% over the last week. Akari Therapeutics was the among the top gainers in the healthcare sector, gaining 255.45% yesterday.

Akari Therapeutics shares are trading higher after the company announced preclinical data demonstrating synergistic activity of AKTX-101 with KRAS inhibition in KRAS-mutated pancreatic cancer models

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -68.4% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 532.26% in the past year. It has overperformed other stocks in the healthcare sector by 591 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 43, which is 28 points higher than the healthcare sector average of 15. It passed 3 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -36.8% in the past year. It has overperformed other stocks in the healthcare sector by 22 percentage points.

Are healthcare stocks a good buy now?

60.49% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.89% over the next year.

4.95% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.38% of healthcare stocks are rated B (Buy), 48.14% are rated C (Hold), 27.48% are rated D (Sell), and 7.05% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.